$AVDL

Avadel Pharmaceuticals plc

  • NASDAQ
  • Health Technology
  • Medical Specialties
  • Manufacturing
  • Medicinal and Botanical Manufacturing

PRICE

$13.63 ▼-1.517%

Extented Hours

VOLUME

388,087

DAY RANGE

13.32 - 14.15

52 WEEK

2.08 - 15.82

Join Discuss about AVDL with like-minded investors

profile
@singletary #StockTraders.NET
recently

sheesh what a fade $avdl

120 Replies 15 👍 11 🔥

profile
@maletone #StockTraders.NET
recently

$AVDL might be a liquidity trap tomorrow also has an event coming up

57 Replies 8 👍 8 🔥

profile
@singletary #StockTraders.NET
recently

missed $avdl by a few seconds. trigger shy will punish you

92 Replies 15 👍 8 🔥

SO
@soheil.n #StockTraders.NET
recently

$AVDL - alerts hit...looking for 2.7 clear out and possibly 2.8 for VPOC from 2 days ago

82 Replies 14 👍 14 🔥

profile
@maletone #StockTraders.NET
recently

$BKSY, watching $AVDL

45 Replies 14 👍 9 🔥

profile
@singletary #StockTraders.NET
recently

watchlist: $siga $bksy $cnce $amc $avdl $husa $tnxp

50 Replies 14 👍 14 🔥

profile
@Chano #StockTraders.NET
recently

will you swing $AVDL? looks like there is still meat

41 Replies 10 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

covered some $AVDL probably goes lower but I want to be mostly cash going into tomorrow

78 Replies 7 👍 14 🔥

profile
@maletone #StockTraders.NET
recently

$AVDL finally

124 Replies 12 👍 8 🔥

profile
@maletone #StockTraders.NET
recently

tighten my stops on $AVDL

121 Replies 11 👍 14 🔥

profile
@singletary #StockTraders.NET
recently

$avdl will long if they re soak 2.2. rather it just fail here

46 Replies 11 👍 7 🔥

profile
@Chano #StockTraders.NET
recently

where did you start on $AVDL?

130 Replies 8 👍 14 🔥

profile
@maletone #StockTraders.NET
recently

came back for more on $AMC & $HUSA but do have small $AVDL just trading siodeways on it

139 Replies 8 👍 7 🔥

profile
@Chano #StockTraders.NET
recently

$AVDL I was waiting a morning push towards r/g but it just never pushed enough

114 Replies 6 👍 14 🔥

profile
@maletone #StockTraders.NET
recently

$AVDL and $SIGA

55 Replies 8 👍 10 🔥

profile
@Chano #StockTraders.NET
recently

$AVDL bouncing

52 Replies 9 👍 10 🔥

profile
@maletone #StockTraders.NET
recently

$siga, $avdl, $bksy, $AMC

108 Replies 13 👍 11 🔥

profile
@singletary #StockTraders.NET
recently

will review this long weekend $govx $oxy $snap $avdl $rdbx $bb $imte $dks $siga $amc $veru and others

143 Replies 14 👍 9 🔥

profile
@maletone #StockTraders.NET
recently

covered the rest of $AVDL flat

100 Replies 10 👍 10 🔥

profile
@singletary #StockTraders.NET
recently

$avdl never touched but that does look annoying lol

70 Replies 8 👍 12 🔥

profile
@maletone #StockTraders.NET
recently

$AVDL nice stuff

42 Replies 11 👍 8 🔥

SO
@soheil.n #StockTraders.NET
recently

ahhh couldn't it just do that when i was in at 2.4 for the long > @Math said: no longer involved $AVDL 2.40s reclaim

57 Replies 14 👍 14 🔥

profile
@Math #StockTraders.NET
recently

no longer involved $AVDL 2.40s reclaim

68 Replies 9 👍 13 🔥

profile
@maletone #StockTraders.NET
recently

sized down my $AVDL short

139 Replies 14 👍 6 🔥

profile
@Math #StockTraders.NET
recently

$AVDL is a pain

137 Replies 12 👍 12 🔥

SO
@soheil.n #StockTraders.NET
recently

sold half at 2.5... > @soheil.n said: $AVDL - lot of volume at 2.8...if it gets there for bag holders to get out

73 Replies 10 👍 14 🔥

SO
@soheil.n #StockTraders.NET
recently

$AVDL - lot of volume at 2.8...if it gets there for bag holders to get out

88 Replies 10 👍 6 🔥

SO
@soheil.n #StockTraders.NET
recently

long some $AVDL - 3x attempt at 2.4 stop 2.32

145 Replies 9 👍 9 🔥

profile
@Math #StockTraders.NET
recently

$AVDL quiet fade hard to get in on SSR

75 Replies 9 👍 6 🔥

profile
@singletary #StockTraders.NET
recently

$avdl nice

91 Replies 7 👍 7 🔥

profile
@maletone #StockTraders.NET
recently

$AVDL fail needs under 2.40s

112 Replies 12 👍 9 🔥

profile
@Chano #StockTraders.NET
recently

$AVDL going for the gap fill on the daily

76 Replies 14 👍 11 🔥

SO
@soheil.n #StockTraders.NET
recently

looking for a push and rejection towards 2.5s before entering...but gotta go for lunch time workout so probably will miss lol > @maletone said: $AVDL tough one

45 Replies 13 👍 9 🔥

profile
@maletone #StockTraders.NET
recently

$AVDL tough one

67 Replies 7 👍 10 🔥

profile
@singletary #StockTraders.NET
recently

$avdl $cnce on watch

145 Replies 9 👍 6 🔥

profile
@singletary #StockTraders.NET
recently

$avdl lil faster

76 Replies 6 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

took some $AVDL short

105 Replies 10 👍 15 🔥

profile
@Math #StockTraders.NET
recently

pretty much sums it up, also $GME $TSLA for me > @maletone said: watchlist: $AVDL, $SIGA, $GOVX, $RDBX

120 Replies 11 👍 12 🔥

profile
@maletone #StockTraders.NET
recently

watchlist: $AVDL, $SIGA, $GOVX, $RDBX

81 Replies 6 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

$jzxn, $RDBX, $AVDL, $ATER

50 Replies 14 👍 6 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Monday, October 18, 2021 U.S. equity futures are looking lower after posting strong gains last week, with oil prices extending their near-term rally into a ninth consecutive week, as concerns over surging inflation pressures and the weakest China growth rate in more than a year tamed optimism linked to a strong start to the third quarter earnings season. Chinese Q3 GDP missed, rising +0.2% q/q vs 0.5% consensus, and was +4.9% y/y vs 5.2% consensus amid a rolling power crisis, supply chain disruptions and a crackdown on the tech sector. In the U.S., the earnings flood begins this week with 72 names in the S&P 500 expected to report quarterly results this week. In corporate news today, Apple (AAPL) is holding its second major launch event of the Fall where it is expected to unveil the first redesign of its MacBook Pro laptop in at least five years (starts at 1:00 PM ET). In Asian markets, The Nikkei Index dipped -43 points to 29,025, the Shanghai Index slipped a few points to settle at 3,568, and the Hang Seng Index rose 78 points to 25,409. In Europe, the German DAX is lower by -0.6% or nearly 100-points to drop below 15,500, while the FTSE 100 dips -0.3% to hold above the 7,200 level. U.S. stocks look to build on last week’s gains where large-cap tech names propelled the advance Friday, with shares of Amazon.com (AMZN) and Tesla (TSLA) each rising more than 3% on no specific news, while the SmallCap Russell 2000 underperformed, falling -0.35% as investors bailed on value stocks for growth stocks. Strong quarterly earnings from Dow component Goldman Sachs (GS) also boosted financials as investors prepare for a flood of reports next week. Shares of cryptocurrency and blockchain-related firms gained last week as bitcoin topped $60,000 for the first time since April, with expectations growing that U.S. regulators would allow a futures-based ETF. Market Closing Prices Yesterday The S&P 500 Index jumped 33.11 points, or 0.75%, to 4,471.37 The Dow Jones Industrial Average rose 382.20 points, or 1.09%, to 35,294.76 The Nasdaq Composite climbed 73.91 points, or 0.50%, to 14,897.34 The Russell 2000 Index declined -8.52 points, or 0.37% to 2,265.65 Events Calendar for Today 9:15 AM ET Industrial Production MoM for September…est. +0.2% 9:15 AM ET Capacity Utilization for September…est. 76.5% 10:00 AM ET NAHB Housing Market Index for October…est. 76 4:00 PM ET Net Long-term TIC Flows for August Earnings Calendar: Earnings Before the Open: ACI, GNTY, STT Earnings After the Close: CFB, ELS, FBK, FNB, HXL, PACW, SFBS, STLD, ZION Other Key Events: Apple (AAPL) announces October 18th event (New MacBooks, a Mac Mini, and AirPods are anticipated) Macro Up/Down Last Nymex 1.43 83.71 Brent 1.11 85.97 Gold -6.70 1,763.50 EUR/USD -0.0012 1.1586 JPY/USD 0.15 114.37 10-Year Note +0.042 1.618% World News China’s industrial output rose +3.1% in September from a year earlier, missing expectations of up +4.5%, and slowing from 5.3% in August, official data showed. Retail sales grew +4.4% in September on-year, compared with a forecast 3.3% increase and a 2.5% rise in August. Fixed asset investment increased +7.3% in the first nine months from the same period a year earlier, missing expectations for a +7.9% rise Chinese Q3 GDP missed, rising +0.2% q/q vs 0.5% consensus; +4.9% y/y vs 5.2% consensus; Chinese Q3 GDP YTD missed +9.8% y/y vs 10.1% consensus; Chinese Sep Unemployment Rate lower: 4.9% vs 5.1% consensus Sector News Breakdown Consumer Lennar ($LEN) said its board increased share repurchase authorization by up to the lesser of $1 billion in purchase price, or 25 million in shares, of the outstanding Class A or Class B common stock Zillow Group ($ZG) is taking a break from buying U.S. homes after the online real estate giant’s pivot into tech-powered house-flipping hit a snag, Bloomberg reported saying after buying more than 3,800 homes in Q2, it will stop pursuing new home purchases as it works through a backlog of properties already in its pipeline Energy, Industrials and Materials S. crude oil futures closed at fresh seven-year highs last week at $82.28 for WTI crude and $8.86 for Brent as a natural gas supply crunch in Europe and optimism about demand in the U.S. continued to propel the recent rally. For the week, WTI rose 3.7% and Brent added 3%, the eighth straight weekly gain for both. Occidental Petroleum ($OXY) upgraded to Buy from Hold at Truist Steel Dynamics ($STLD) downgraded to Equal Weight from Overweight at Morgan Stanley and firm also downgraded S. Steel (X) to Underweight from Equal Weight Virgin Galactic ($SPCE) downgraded to Sell from Neutral at UBS with $15 tgt Healthcare Biogen Inc’s ($BIIB) said a late-stage experimental treatment for an inherited form of amyotrophic lateral sclerosis (ALS) failed to reach its main goal, but secondary measures and biomarkers showed favorable trends. Tofersen is designed to suppress the production of SOD1, a protein that can accumulate to toxic levels in ALS patients with mutations in a specific gene. Revance ($RVNC) shares fell over -30% late Friday after the FDA declined to approve its frown line injection treatment, citing issues with the company’s manufacturing facility; o other concerns were raised by the agency Avadel ($AVDL) shares slide over -20% after saying the U.S. FDA notified the co that the agency is still reviewing the marketing application of its sleep disorder drug, FT218, and the decision will likely not be taken this month (prior review was expected by Oct. 15) Omeros Corporation ($OMER) said they received a Complete Response Letter (CRL) from the U.S. FDA regarding its Biologics License Application ($BLA) for narsoplimab in the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy ($HSCT-TMA). PTC Therapeutics ($PTCT) downgraded to Underperform from Neutral at Bank America with a $38 price target Oyster Point Pharma ($OYST) announced that the FDA has approved Tyrvaya Nasal Spray 0.03 mg for the treatment of the signs and symptoms of dry eye disease MeiraGTx ($MGTX) mentioned positively in Barron’s saying shares could more than double as the company will present its gene-regulating “switches” at next week’s conference of the European Society of Gene and Cell Therapy, and to Wall Street investors in mid-December. Notes shares have fallen from a 2019 peak of $30 to a recent $14, leaving its market cap below $600 million The plan to roll out Merck & Co’s ($MRK) promising antiviral pill to treat COVID-19 risks repeating the inequities of vaccine distribution, potentially leaving the nations with the greatest need once again at the back of the line, international health groups say – Reuters Technology, Media & Telecom Dell Inc. ($DELL) with a positive mention in Barron’s saying the company is about to become much more attractive to investors as it prepares to spin off its valuable stake in software maker VMware (VMW) in early November, arguing that Dell will emerge with a solid balance sheet and simpler structure. Netflix ($NFLX) estimates that its latest megahit, “Squid Game,” will create almost $900 million in value for the company, and only cost about $21M to make. Netflix estimates that 89% of people who started the show watched at least 75 minutes – more than one episode – and 66% of viewers, or 87 million people, have finished the series in the first 23 days Disney ($DIS) downgraded to Equal Weight from Overweight at Barclays and cut tgt to $175 from $210 Members of a congressional committee questioned whether Amazon (AMZN) executives misled them during an investigation of the company’s business practices and if they may have lied under oath – WSJ reports Upstart ($UPST) downgraded to Underperform from Neutral at Bank America saying the LT thesis intact, but near-term upside priced in

71 Replies 13 👍 15 🔥

profile
@dros #droscrew
recently

+Initiations 9/23: $ANXX $AOSL $AVDL $AVXL $BIIB $BTBT $DNMR $FSR $GTLS $HRMY $ITCI $JAZZ $JOBY $KNTE $LABP $LIDR $MCG $MRTX $OVV $OXLC $PCT $RBC $RPD $RPTX $SAGE $SFET $SITC $SWBK $UE $XFLT . -Initiations 9/23: $TSLA

131 Replies 7 👍 6 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Thursday, September 23, 2021 Futures Up/Down % Last Dow 162.00 0.47% 34,291 S&P 500 23.25 0.53% 4,407 Nasdaq 83.50 0.55% 15,247 U.S. stocks are looking at another move higher following strong gains on Wednesday despite the FOMC taking a more “hawkish” stance on both rates and the timeline on asset purchase tapering during yesterday’s meeting. Stocks jumped on Wednesday after the Federal Reserve cleared the way to ease monthly bond purchases “soon” and signaled interest rate increases may follow more quickly than expected. Stocks pared gains late as Fed Chair Jerome Powell spoke at his press conference but still closed up solidly. Fed officials indicated that they see interest rates seen rising to 1% in 2023, faster than projected by the Fed in its projections in June, and then to 1.8% in 2024. Nine of eleven major S&P 500 sectors ended the day higher. However, of note, all 11 groups retreated from the moments before Powell’s press conference began, into the close. The Dow Transport index slid to 6-month lows following weakness from Fed-Ex (FDX) earnings results and guidance the night prior. In Asian markets, The Nikkei Index was closed, the Shanghai Index rose 13 points to 3,642 and the Hang Seng Index gained 289 points to 24,510. In Europe, the German DAX is up over 130 points (0.89%) to 15,645, while the FTSE 100 rises about 20-points to move above 7,100. Oil prices are slipping but still holds near two-month high with global stockpiles tightening. In China news, the WSJ reported China is preparing for the “demise” of Evergrande, signaling Beijing’s reluctance to get involved and bail out the company. Events Calendar for Today 8:30 AM ET Weekly Jobless Claims…est. 320K 8:30 AM EST Continuing Claims…est. 2.65M 9:45 AM ET Markit Manufacturing PMI, Sept-F…est. 61.5 9:45 AM ET Markit Services PMI, Sept-F…est. 55.0 9:45 AM ET Markit Composite PMI-Sept-F 10:00 AM ET Leading Index MoM for Aug…est. +0.7% 10:30 AM ET Weekly EIA Natural Gas Inventory Data 11:00 AM ET Kansas City Fed Manufacturing for Sept…prior 22 Earnings Calendar: Earnings Before the Open: DRI, DYNT, IWSY, RAD Earnings After the Close: AEHR, AGTC, AIR, CAMP, $COST, MTN, $NKE, PRGS, $RSSS Other Key Events: Credit Suisse 7th Annual Oil & Gas Non-Bus Tour (virtual), 9/21-9/23 DA Davidson Diversified Industrials & Services Conference (virtual), 9/22-9/23 Goldman Sachs 30th Annual Communacopia Conference (virtual), 9/21-9/23 JPMorgan 12th Annual U.S. All Stars Conference (virtual), 9/21-9/23 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (virtual), 9/20-9/23 Roth Capital 8th Annual Solar Symposium (virtual), 9/20-9/23 Sidoti Fall Small Cap Conference (virtual), 9/22-9/23 Wells Fargo 4th Annual Consumer Conference (virtual), 9/22-9/23 Market Closing Prices Yesterday The S&P 500 Index gained 41.45 points, or 0.95%, to 4,395.64 The Dow Jones Industrial Average rose 338.48 points, or 1.00%, to 34,258.32 The Nasdaq Composite jumped 150.45 points, or 1.02%, to 14896.85 The Russell 2000 Index advanced 32.38 points, or 1.48% to 2,218.56 Macro Up/Down Last Nymex -0.32 71.91 Brent -0.27 75.92 Gold 3.80 1,772.00 EUR/USD 0.0028 1.1715 JPY/USD 0.11 109.89 10-Year Note +0.003 1.335% World News China is preparing for the “demise” of Evergrande, signaling Beijing’s reluctance to get involved and bail out the company (the gov’t will only step in should the company’s failure turn disorderly) – WSJ https://on.wsj.com/3i2x8WH Sector News Breakdown Consumer Steelcase ($SCS) 2Q EPS $0.21 vs est. $0.23 on revs $724.8Mm vs est. $761.3Mm; guides 3Q revs $755-785Mm vs est. $713Mm, sees 3Q EPS $0.07-0.11 vs est. $0.09 Funko ($FNKO) entered into a new credit agreement for a term loan facility of $180M and a revolving credit facility of $100M that mature September 17, 2026 Brilliant Earth ($BRLT)33M share IPO priced at $12.00 Hyatt ($H) 7M share Secondary priced at $74.50 Sovos Brands ($SOVO)3M share IPO priced at $12.00 Energy, Industrials & Materials HB Fuller (FUL) 3Q adj EPS $0.79 vs est. $0.79 on revs $827Mm vs est. $797.6Mm; guides FY revs +17-18% vs est. +14.4%, sees FY adj EBITDA abut $460-470Mm vs est. $463Mm KB Homes (KBH) 3Q EPS $1.60 vs est. $1.62 on revs $1.47B vs est. $1.57B; qtrly homes delivered +35% to $3,425, ending backlog value +89% to $4.84B; inventory +19% to $4.66B as of Aug. 31; repurchased 4.7Mm shares for $188.2Mm Northrop Grumman ($NOC) upgraded to Neutral from Sell at Goldman Sachs with a $350 price target and General Dynamics (GD) also upgraded to Neutral from Sell at Goldman Sachs with a $176 price target in the defense sector; L3Harris Technologies (LHX) downgraded to Sell from Neutral at Goldman Sachs with a $207 price target, Lockheed Martin (LMT) downgraded to Neutral from Buy with $402 tgt and Woodward ($WWD) downgraded to Sell from Neutral with $102 tgt Loop Capital started Regal Beloit Corp (RBC) with a Buy rating and $180 price target and Timken (TKR) with a Hold rating and $72 price target Grinrod Shipping ($GRIN)842M share Spot Secondary priced at $13.50 Syncrude Canada, majority-owned by Suncor Energy ($SU), cut September supplies due to a mechanical disruption at its Alberta oil sands site, Bloomberg reported Financials Chinese Estates (Holdings) Ltd. is planning to sell all of its shares in China Evergrande Group, as the property investment company is worried about the recent stock-price volatility and financial condition of debt-laden Evergrande. Chinese Estates, which currently holds 751.09 million shares or a 5.66% stake in Evergrande, expects to record a realized loss on the stake of about 1.38 billion Hong Kong dollars ($177.2 million) for the year ending December Remitly Global (RELY)16M share IPO priced at $43.00 The9 ($NCTY), Polygon, an Ethereum scaling platform, and Protocol Labs, a major contributor of open-source projects are forming an ecosystem collaboration on NCTY’s Non-Fungible Token (NFT) platform NFTSTAR and GameFi Play-to-Earn projects Safehold (S$AFE)2M share Secondary priced at $76.00 Willis Towers Watson ($WLTW) raises share buyback program by $4B Raymond James Financials ($RJF) posts Private Client Group assets in fee-based accounts of $643.5B grew 33% Y/Y, thanks to the net addition of financial advisers; record client assets under administration of $1.21T rose from $945.2B in the year ago period and $1.18T in the prior month. Healthcare The FDA has granted Emergency Use Authorization for a booster dose of Pfizer ($PFE)/BioNTech’s ($BNTX) COVID-19 vaccine for those 65 and older, those who work in healthcare settings, and adults at high risk of severe COVID-19. The authorization includes people whose “frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of COVID-19.” Sterling Check (STER)285M share IPO priced at $23.00 Eargo, Inc. (EAR) shares fell -50% on reports it is the target of a criminal investigation by U.S. DOJ related to insurance reimbursement claims submitted on behalf of customers covered by federal employee health plans; the co is withdrawing its financial guidance for fiscal year ending December 31, 2021 Spectrum Pharma (SPPI) Journal of Clinical Oncology Abstract listing for co.’s ‘poziotinib for patients with HER2 exon 20 mutant non–small-cell lung cancer Cigna Corp (CI) named Eric Palmer as president and chief executive officer of Evernorth, its health services unit that mainly houses its pharmacy benefit management business; also announced several other leadership changes Medirom Healthcare (MRM) rises 39%; after saying that it will buy Japanese private hair salon operator Zacc Kabushiki Kaisha in an all-cash deal of 370.0 mln yen ($3.36M) Thorne HealthTech (THRN) 7M share IPO priced at $10.00 Stifel initiated Buy ratings on Mirati Therapeutics (MRTX) with a $202 price target, Kinnate Biopharma (KNTE) with a $32 price target, and Repare Therapeutics (RPTX) with a $48 price target; Hold ratings on Ideaya Biosciences (IDYA) and Revolution Medicines (RVMD) Needham started SAGE Therapeutics (SAGE) at a Buy and added it to its Conviction List; also initiated Buy ratings on Intra-Cellular Therapeutics (ITCI), Avadel Pharmaceuticals (AVDL), Jazz Pharmaceuticals ($JAZZ), Biogen ($BIIB), Harmony Biosciences ($HRMY), and Hold ratings on Neurocrine Biosciences ($NBIX) and ACADIA Pharmaceuticals (ACAD) Technology, Media & Telecom Blackberry ($BB) shares rose 8% after earnings; Q2 EPS ($0.06) vs est. ($0.07) on revenue $175M vs est. $163.5M Facebook ($FB) chief technology officer Mike Schroepfer said in a Facebook post: “After 13 amazing years at Facebook, I have made the decision to step down as Chief Technology Officer and transition to a new part time role as Facebook’s first Senior Fellow at the company sometime in 2022 EngageSmart ($ESMT)55M share IPO priced at $26.00 Roku ($ROKU) upgraded to Buy from Neutral at Guggenheim

76 Replies 15 👍 12 🔥

profile
@truublue #droscrew
recently

$Avdl over 50ma

110 Replies 7 👍 15 🔥

profile
@truublue #droscrew
recently

https://twitter.com/glareone/status/1328396317991841794?s=21 watching $avdl have some shares

112 Replies 12 👍 15 🔥

Key Metrics

Market Cap

1.06 B

Beta

1.39

Avg. Volume

1.28 M

Shares Outstanding

76.77 M

Yield

0%

Public Float

0

Next Earnings Date

2023-08-09

Next Dividend Date

Company Information

Avadel Pharmaceuticals plc is a biopharmaceutical company primarily focused on the development and FDA approval of FT218, an investigational, once-nightly, extended-release formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy.

CEO: Gregory Divis

Website:

HQ: Block 10-1 Blanchardstown Corporate Park Dublin, 15 Dublin

Related News